Low-density (LD) lipoproteins inhibit phytohaemagglutinin-enhanced turnover of phosphatidylinositol in human peripheral lymphocytes. Turnover 
the inhibitory lipoproteins appear to be resting lymphocytes (Curtiss & Edgington, 1977) . Inhibition by LD lipoproteins of lymphocyte response to phytohaemagglutinin is not the result of inhibition of mitogen-cell interaction, or of alteration in the amount of phytohaemagglutinin required to elicit maximum cellular response (Hui et al., 1979) . Moreover, the immunosuppressive activity of LD lipoproteins appears to be distinct from the ability of the lipoproteins to down-regulate cholesterol biosynthesis in lymphocytes. Cholesterol-depleted LD lipoproteins are as active as native LD lipoproteins in preventing lymphocyte activation (Hui et al., 1979) . LD lipoproteins also inhibit activation of lymphocytes obtained from patients with familial hypercholesterolaemia (Curtiss & Edgington, 1978; Hui et al., 1979) ; the cholesterol-synthesizing machinery of lymphocytes isolated from familialhypercholesterolaemia donors is not subject to regulation by LD lipoproteins (Ho et al., 1976) . Suppression of phytohaemagglutinin-elicited lymphocyte activation appears to be a direct consequence of lipoproteins binding to the cell membrane since removal of LD lipoproteins from the cell surface with heparin reverses inhibition (Hui et al., 1979) . Immunosuppression by LD lipoproteins may thus be the direct result of an alteration of the lymphocyte plasma membrane, which renders the cell non-responsive to the mitogenic signal.
Interaction of LD lipoproteins with lymphocytes inhibits early events elicited by phytohaemagglutinin which are required for induction of cell proliferation. Specifically, LD lipoproteins inhibit phytohaemagglutinin-enhanced accumulation of Ca2+ (Hui et al., 1979) and cyclic GMP (Hui & Harmony, 1979a ) by lymphocytes; inhibition correlates directly with inhibition by LD lipoproteins of DNA synthesis. An additional lymphocyte-membrane-associated phenomenon that occurs immediately after addition of phytohaemagglutinin is an increased rate of phospholipid metabolism. During the first hours after stimulation, phytohaemagglutinin enhances the incorporation of [32pIp into phosphatidylinositol without affecting [32p1p1 incorporation into other major phospholipids (Fisher & Mueller, 1968; Maino et al., 1975) . This increase in [32P] phosphatidylinositol is due to the enhanced turnover of the phosphoinositol group of phosphatidylinositol and not to increased biosynthesis of the phospholipid subsequent to stimulation. Since an increased rate of phosphatidylinositol turnover has been implicated as the initial event in the coupling of ligand-receptor interactions and Ca2+ transport (Allan & Michell, 1977) (Nelson, 1972) and similar to that reported previously (Hui & Harmony, 1979b) . Human peripheral blood lymphocytes, obtained by centrifugation of the blood through Ficoll-Paque (Boyum, 1968) , were washed twice with 150mM-NaCl. Lymphocytes were further purified from contaminating adherent cells as described by Hui et al. (1979) . Accumulation of 45Ca2+ by lymphocytes was determined by the method of Hui et al. (1979) .
The influence of LD lipoproteins and phytohaemagglutinin on phospholipid metabolism in lymphocytes was assessed by determining the amount of 32p incorporated into the lipids. In a typical experiment, 1 x 106 cells suspended in 1 ml of phosphate-free Hanks' balanced salt solution (pH adjusted to 7.0) were incubated with or without added lipoproteins at 37°C in an atmosphere of C02/air (1: 19). After 1 h, [32P]phosphoric acid (l00uCi; New England Nuclear) was added to the suspension followed immediately by the addition of phytohaemagglutinin (Sigma Chemical Co.). The phytohaemagglutinin used had optimum mitogenic activity at the concentration of 3,ug/ml (Hui et al., 1979 Lowry et al. (1951) , with 1% sodium dodecyl sulphate to solubilize the samples and bovine serum albumin as standard. Total phospholipid was measured as phosphorus by the method of Bartlett (1959) . Cholesterol and cholesteryl esters were determined by the method of Roeschlau et al. (1974) 
Results
Phytohemagglutinin stimulates 32p incorporation into phosphatidylinositol in lymphocytes (Fisher & Mueller, 1971) . As shown in Fig. 1 phytohaemagglutinin (3,pg/ml). The incubations were continued for 1 h and the reactions were terminated by centrifugation to pellet the lymphocytes. The cells were washed twice in 150mM-NaCl and lysed in 0.5 M-HCI; the lipids were extracted in methanol/chloroform (1:2, v/v). Phospholipids were identified by t.l.c. as described in the Materials and methods section. Radioactivity associated with phosphatidylinositol (A, x and 0) and phosphatidylethanolamine (A and 0) was determined by liquid-scintillation spectrometry in Aquasol.
haemagglutinin-stimulated lymphocytes depends on the concentration of LD lipoproteins present in the incubation medium. As shown in Fig. 4 , 50% of maximum inhibition occurs at a low-density-lipoprotein protein concentration of about 33,ug/ml, maximum inhibition of phytohaemagglutinin-induced phosphatidylinositol turnover occurs at lowdensity-lipoprotein protein concentrations greater than lOO,g/ml. LD lipoproteins at concentrations as high as 200,g of protein/ml have no effect on 32p incorporation into phosphatidylinositol in the absence of phytohaemagglutinin.
The concentrations of LD lipoproteins that inhibit 32p incorporation into phosphatidylinositol by 50 and 100% of maximum (Fig. 4) respectively are quite similar to the concentrations, 22 and lOO,ug/ml (Hui et al., 1979) Fig. 4 denion- (Table la) . This result, which indicates a continuous breakdown of phosphatidylinositol when lymphocytes are incubated in the presence of phytohaemagglutinin, agrees with the report that phytohaemagglutinin stimulates the breakdown of phosphatidylinositol (Fisher & Mueller, 1968 1-10mM) and N-acetylgalactosamine (1mM), which inhibit lymphocyte proliferation (Lindahl-Kiessling, 1972; Diamanstein & Ulmer, 1975) and dibutyryl cyclic GMP (10mM), which potentiates lymphocyte activation (Diamanstein & Ulmer, 1975) , are relatively ineffective in suppressing phytohaemagglutinin-induced breakdown of phosphatidylinositol (Table lb) .
Discussion
Much of the inositol in eukaryotic cells is present as phosphatidylinositol in cell membranes. In response to extracellular stimuli, enhanced turnover of the phosphoinositol group of phosphatidylinositol occurs by what appears to be a closed cycle of reactions (Michell, 1975 (Allan & Michell, 1974 , 1977 Michell, 1975) . The Ca2+ ionophore A23187 also stimulates 32p incorporation into phosphatidylinositol (Greene et al., 1976; Allan & Michell, 1977) , and inclusion of EGTA in the incubation medium inhibits phosphatidylinositol-stimulated 32p incorporation (Allan & Michell, 1977) . However, since at identical EGTA concentrations phytohaemagglutinin-enhanced 45Ca2+ accumulation is abolished completely and 32p incorporation into phosphatidylinositol is decreased by 35% only, Allan & Michell (1977) conclude that Ca2+ is not the primary factor that controls phosphatidylinositol turnover. These investigators further suggest that the ionophore-triggered Ca2+ accumulation in the cell cytoplasm may increase 32p incorporation by increasing the availability of diacylglycerol for the synthesis of phosphatidylinositol, and phytohaemagglutinin may stimulate phosphatidylinositol turnover per se resulting in enhanced accumulation of 45Ca2+ (Allan & Michell, 1977 . Ca2+ is a putative second messenger in lymphocyte activation.
Under the conditions of the experiments reported in the present paper, both EGTA and LD lipoproteins inhibit the release of 32p from [32P]phosphatidylinositol. However, the effects of suboptimal concentrations of LD lipoproteins and EGTA are additive, suggesting that both inhibitors suppress the same step in the phosphatidylinositol cycle, though perhaps by distinct mechanisms. It is likely that EGTA inhibits phosphatidylinositol breakdown by depleting lymphocytes of cellular Ca2 , thus inhibiting the phosphatidylinositol-specific phospholipase C in lymphocytes (Allan & Michell, 1974) . This enzyme, when assayed in soluble lymphocyte extracts, is exquisitely dependent on Ca2+ for activity (Allan & Michell, 1974) . Although it is tempting to propose that LD lipoproteins inhibit phytohaemagglutinin-enhanced 45Ca2+ accumulation, which in turn inhibits phosphatidylinositol turnover by preventing the degradation step, inhibition of phosphatidylinositol turnover by LD lipoproteins may be the result of an alteration in the responsiveness of the lymphocyte membrane to mitogenic stimulation which is unrelated to Ca2+ transport. The data do not distinguish between the two possibilities. The second possibility is consistent with the phosphatidylinositol-+Ca2+ sequence sug-gested by Allan & Michell (1977 , the first is not. In any case, the fact that LD lipoproteins inhibit phosphatidylinositol turnover and 4'Ca2+ accumulation by phytohaemagglutinin-challenged lymphocytes is important.
The mechanism by which LD lipoproteins inhibit the events of lymphocyte activation that occur immediately after mitogenic challenge is not known. Three possibilities exist: (1) lipoproteins exert a suppressive influence simply by binding to the lymphocyte surface and, as a consequence of this lipoprotein-membrane interaction, alterations in membrane functions due to mitogenic activation are suppressed; (2) inhibition by LD lipoproteins requires the internalization and degradation of the lipoproteins, processes involved for regulation of cellular cholesterol biosynthesis by LD lipoproteins; or (3) inhibition is the result of lipoproteinzcellsurface-lipid transfer. The experimental evidence supports mechanism (1). First, both cellular accumulation of 45Ca2+ and phosphatidylinositol turnover are believed to be the result of alterations in the plasma membrane of the cell (Michell, 1975; Greene et al., 1976) . Secondly, inhibition by LD lipoproteins of lymphocyte activation is reversed by the addition of heparin and reversal of inhibition correlates with heparin-induced removal of 1251-labelled LD lipoproteins from the cell surface (Hui et al., 1979) . Thirdly, addition of LD lipoproteins 5h after phytohaemagglutinin stimulation of lymphocytes results in rapid and almost complete release of 43Ca2+ from the cells without concomitant dissociation of phytohaemagglutinin from the cell membrane. Fourthly, cholesterol-depleted LD lipoproteins, prepared by the method of Gustafson (1965) , are more potent than native LD lipoproteins in preventing phytohaemagglutinin activation of lymphocytes . Cholesteroldepleted LD lipoproteins do not regulate cholesterol biosynthesis in cultured cells (Steinberg et al., 1978) , indicating that the immunosuppressive activity of LD lipoproteins is independent of suppression by LD lipoproteins of cholesterol biosynthesis. Finally, LD lipoproteins covalently linked to Sepharose beads are as effective as native LD lipoproteins in the inhibition of lymphocyte stimulation induced by phytohaemagglutinin (Steinberg et al., 1978) , providing additional support for the conclusion that LD lipoproteins inhibit lymphocyte activation by binding to the cell membrane.
The physiological significance of the immunoregulatory properties of plasma lipoproteins may be that excess LD lipoproteins increase the susceptibility of the host to atherosclerosis. This latter hypothesis is based on the suggestion that viralinduced changes in the smooth muscle of blood vessels may have a role in the atherogenic process (Benditt & Benditt, 1973; Burch, 1974) . If this hypothesis proves to be correct, patients in whom the immune process within the intravascular compartment is suppressed by lipoproteins will be more susceptible to viral-induced changes in the arterial wall. Moreover, the results presented herein support our hypothesis that specific plasma lipoproteins regulate cell physiology via the cell membrane (Hui & Harmony, 1979b,c; Hui et al., 1979) . In addition to suppression of 4'Ca2+ accumulation and phosphatidylinositol turnover in activated lymphocytes, LD lipoproteins promote agglutination of erythrocytes by concanavalin A (B. , activate Mg2+-dependent ATPase in erythrocyte membranes (V. , increase [cyclic AMP] in thrombocytes (Taylor et al., 1979) , and activate adipocyte-membrane adenylate cyclase (Pairault et al., 1977) . The hypothesis provides a working model for studying the role of lipoproteins in normal and in pathological states.
